Eagle Pharmaceuticals, Inc. (“Eagle” or “the Company”) (Nasdaq:EGRX) today announced its financial results for the transitional three-month period ended December 31, 2014 (the “stub period”). This stub period resulted from the previously-announced change in Eagle’s year end from September 30 to December 31. The company will report financial results of the first quarter of 2015 in May.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
